CROs offering Medicinal Chemistry with Small Molecule
31 published
31 published CROs match Medicinal Chemistry and Small Molecule.
Locations in this set include United States, China, Canada, India, United Kingdom, and France.
Capabilities that show up most often in this set: Discovery Research, Computational & In-Silico Drug Discovery, High-Throughput Screening, Target Identification & Validation, and In Vitro ADME / DMPK.
Matching companies
ProtheragenSpecialized preclinical CRO dedicated to obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.- R2M Pharma, Inc.R2M Pharma is a medicinal chemistry CRO specializing in small-molecule drug discovery and preclinical development, from hit validation through GLP toxicology studies.
ResolveMass Laboratories Inc.Canadian CRO and CDMO specializing in polymer synthesis, peptide characterization, and advanced analytical services for drug delivery and pharmaceutical development. FDA-registered and ISO 9001:2015 certified, serving North American pharmaceutical and biotech companies.
SelvitaSelvita is an integrated drug discovery and development service provider offering comprehensive solutions from target validation through preclinical candidate nomination and clinical manufacturing, with expertise in small molecules, antibodies, and protein degraders.
Sparge Chem Pvt. Ltd.Pune-based provider of custom synthesis, medicinal chemistry, process development, and CRAMS/CDMO services for drug discovery and API intermediates. Offers FTE and fee-for-service engagement models with a 24-hour feasibility response.
SteerOn ResearchDiscovery chemistry CRO offering computational, medicinal, synthetic, and analytical chemistry services alongside regulatory support including PDE/OEL assessments, genotoxicity evaluations, and pharmacovigilance for pharmaceutical and biotech clients.
Sygnature DiscoveryIntegrated drug discovery CRO covering target identification through lead optimization, with computational design, structural biology, medicinal chemistry and DMPK support. Serves biotech and pharma clients across the US, Canada, UK and Europe.
Synfini, Inc.Synfini provides AI-driven drug discovery services from target selection through lead optimization, combining cloud-based AI design tools with robotic wet lab automation to accelerate DMTA cycles across diverse chemical modalities and therapeutic indications.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
TigermedLeading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.
WuXi AppTecGlobal CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.
Markdown mirror: /explore/medicinal-chemistry/small-molecule.md